Samuel Agresta's Insider Trades & SAST Disclosures
Samuel Agresta's most recent trade in OnKure Therapeutics Inc. - Ordinary Shares - Class A was a trade of 45,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Samuel Agresta.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| OnKure Therapeutics Inc. -... | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2025 | 45,000 | 45,000 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc. -... | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 131,396 | 131,396 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc. -... | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 18,588 | 18,588 | - | - | Employee Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Aug 2023 | 311,297 | 0 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.25 per share. | 16 Aug 2023 | 311,297 | 0 | - | 8.2 | 2,568,200 | Common Stock |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.72 per share. | 16 Aug 2023 | 311,297 | 311,297 | - | 3.7 | 1,158,025 | Common Stock |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Infinity Pharmaceuticals Inc. | Samuel Agresta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(right to buy) | |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| Infinity Pharmaceuticals Inc. | Samuel Agresta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Infinity Pharmaceuticals Inc. | Samuel Agresta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 30,000 | 30,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges